The IPSE Diversity Internship Program at Nephron will be a 12-week experience offering graduate or undergraduate students in their junior or senior year the chance to spend the summer working on priority projects for the West Columbia-based developer and producer of generic inhalation solutions and suspension products.
“We pride ourselves on two things: First, we do everything we can to make sure that everyone has a chance to achieve their dreams, and second, we utilize interns and apprentices in everything we do. They are playing key roles in our expansion and growth,” Lou Kennedy, owner and CEO of Nephron, said in a news release. “This is why I am so excited to partner with the ISPE Foundation to rollout these new internship opportunities. They represent a win-win for participants and for our company. We are proud to invest in talented young people, and we are excited they want to invest in us. We cannot wait to get started.”
Internships are available in departments including analytical services and formulation, molecular biology and engineering. Applications are due May 6.
“I am delighted and honored to announce the partnership of Nephron Pharmaceuticals with the ISPE Foundation on its Diversity Internship Program,” said Antonio Moreira, ISPE Foundation board chair and vice provost for academic affairs at the University of Maryland Baltimore County. “Over the coming years, a diverse pool of very talented students will be engaged in a variety of technologically stimulating projects under the guidance and mentorship of Nephron Pharmaceuticals scientists and engineers. These life-changing experiences will inspire the interns to continue pursuing the many career opportunities that the pharmaceutical industry offers to these future leaders.”